by CCHR National Affairs Office | Sep 20, 2023
High potential for abuse and overdose of prescription stimulants prompts U.S. Food and Drug Administration to research alternative treatments. Prescription stimulants commonly prescribed for behavior labeled attention-deficit hyperactivity disorder (ADHD) are promoted...
by CCHR National Affairs Office | Sep 14, 2023
Publication bias contributes to misperception by doctors that antidepressants are safer, more effective than they really are, new study suggests. Psychiatric journals are less likely to publish studies that find antidepressants increase the risk of suicide than...
by CCHR National Affairs Office | Sep 7, 2023
Women taking antidepressants who are, or are planning to become, pregnant can discuss these risks with their physicians. A new study indicates that expectant mothers’ use of antidepressants during pregnancy may negatively affect the brain development of...
by CCHR National Affairs Office | Aug 30, 2023
Study is latest to find that children traumatized by removal from their families and homes are prescribed powerful psychotropic drugs at high rates. A new government study has found that one in four Medicaid-enrolled children under the age of 18 in the U.S. child...
by CCHR National Affairs Office | Aug 24, 2023
Previous government recommendations for improved oversight of psychotropics in foster care have not resolved the overdrugging problem. Despite government recommendations over more than a decade for more oversight of the psychotropic drugs given to foster children, a...
